MAP2 Protein

Overview

MAP2 Protein
Protein Symbol	MAP2
Protein Name	Microtubule-Associated Protein 2
Aliases	MAP-2, MAP2A, MAP2B, MAP2C, MAP2D
Chromosomal Location	2q34-q35
Entrez Gene ID	4135
UniProt ID	P29536
Isoforms	Multiple (MAP2A, MAP2B, MAP2C, MAP2D)
Tissue Specificity	Neuron-specific
Domain	Position
N-terminal projection domain	1-1500 aa
Microtubule-binding domain	1500-1800 aa
C-terminal domain	1800-2000+ aa
Isoform	Molecular Weight
MAP2A	~200 kDa
MAP2B	~200 kDa
MAP2C	~70 kDa
MAP2D	~200 kDa
Dendritic localization	Concentrated in dendritic shafts and spines
Spine morphology	Regulates dendritic spine shape and stability
Synaptic targeting	Localizes to postsynaptic densities
Signal transduction	Scaffold for signaling molecules
Change	Description
Reduced immunoreactivity	Decreased MAP2 staining
Dendritic degeneration	Beading, fragmentation
Colocalization with plaques	MAP2 around amyloid
Correlation with cognition	MAP2 loss tracks dementia
Disease	MAP2 Relationship
Huntington's disease	Reduced MAP2 in striatal neurons
Frontotemporal dementia	Tau pathology affects MAP2
Multiple sclerosis	Marker of demyelination damage
Traumatic brain injury	MAP2 as injury biomarker
Mechanism	Description
Microtubule disruption	Loss of stabilization leads to transport defects
Synaptic loss	Reduced synaptic MAP2 precedes neuron death
Phosphorylation imbalance	Abnormal kinases/phosphatases affect MAP2
Proteasomal degradation	Increased MAP2 cleavage in disease
Biomarker Use	Application
Neuronal injury	CSF/serum MAP2
Disease progression	Brain MAP2 loss
Therapeutic monitoring	MAP2 recovery
Autopsy tissue	MAP2 immunostaining
Partner	Interaction Type
β-Tubulin	Direct binding
Tau	Competition
PSD-95	Scaffold binding
NMDA receptor	Direct binding
CaMKII	Phosphorylation
MARK kinases	Phosphorylation
Fyn kinase	Phosphorylation
Region	MAP2 Expression
Hippocampus	Very high (CA1-CA3, dentate gyrus)
Cerebral cortex	High (layers II-VI)
Cerebellum	Moderate (Purkinje cell dendrites)
Basal ganglia	Moderate
Brainstem	Lower
Kinase	Site
CaMKII	Multiple serine/threonine
PKA	Serine residues
MARK/PAR-1	KXGS motifs
GSK-3β	Multiple sites
CDK5	Proline-directed sites
Associated Diseases	AD, ALI, ALS, AMI, Aging
KG Connections	140 edges

MAP2 (Microtubule-Associated Protein 2) is a neuronal cytoskeletal protein that plays critical roles in stabilizing microtubules, maintaining dendritic architecture, and regulating synaptic function. As one of the most abundant proteins in neurons, MAP2 is essential for proper neuronal development, axonal transport, and plasticity. It serves as a key biomarker for neuronal injury and is heavily implicated in the pathogenesis of Alzheimer’s disease and other neurodegenerative disorders. ^{1MAP2 isoforms (1999)1999 · DOI 10.1016/S0165-5728(98Open reference}

Protein Structure and Isoforms

Structural Architecture

MAP2 is a large protein with distinct structural domains:

Isoforms

The MAP2 gene produces multiple isoforms through alternative splicing:

Microtubule-Binding Repeat Regions

MAP2 contains 3-4 repeat sequences in its microtubule-binding domain:

Repeat 1: 1766-1790 aa
Repeat 2: 1791-1815 aa
Repeat 3: 1816-1840 aa
Repeat 4 (if present): 1841-1865 aa

These repeats bind to the C-terminal tails of β-tubulin, stabilizing microtubule structure.

Biological Functions

Microtubule Stabilization

MAP2’s primary function is stabilizing neuronal microtubules:

• Polymer protection: Prevents microtubule depolymerization

• Bundle formation: Organizes microtubules into parallel bundles

• Transport facilitation: Enables microtubule-based transport

• Dynamic regulation: Modulates microtubule dynamics

Dendritic Architecture

MAP2 is specifically enriched in dendrites (not axons):

Synaptic Function

MAP2 plays essential roles at synapses:

1. Postsynaptic scaffold: Links postsynaptic densities to cytoskeleton

2. Receptor anchoring: Interacts with NMDA and AMPA receptors

3. Signal integration: Scaffold for multiple signaling pathways

4. Plasticity modulation: Involved in LTP and LTD

Developmental Roles

• Neuronal differentiation: Guides neuronal polarity establishment

• Dendritogenesis: Essential for dendritic tree formation

• Synaptogenesis: Regulates synapse formation and maturation

• Migration: Modulates neuronal migration in developing brain

Role in Neurodegenerative Diseases

Alzheimer’s Disease

MAP2 is intimately involved in AD pathogenesis:

Tau Pathology Interaction

• Competition for binding: Hyperphosphorylated tau competes with MAP2 for microtubule binding

• Loss of function: Tau pathology reduces MAP2-microtubule interaction

• Structural destabilization: Combined loss leads to dendritic breakdown

• Diagnostic marker: MAP2 immunoreactivity reflects neuronal integrity

Changes in Alzheimer’s Brain

Parkinson’s Disease

• Dendritic vulnerability: Dopaminergic neuron dendrites affected

• Synaptic dysfunction: Loss of synaptic MAP2

• α-Synuclein interaction: Potential crosstalk with microtubule function

• Therapeutic implications: MAP2 as intervention target

Other Neurodegenerative Conditions

Mechanisms of Neurodegeneration

Clinical Significance

Biomarker Applications

Therapeutic Target Potential

• Microtubule stabilization: Compounds to enhance MAP2 function

• Phosphorylation modulation: Kinase/phosphatase targeting

• Gene therapy: MAP2 expression restoration

• Small molecule stabilizers: Taxol-like compounds

Interactions and Pathway Membership

Protein Interactions

Pathway Involvement

MAP2 participates in several key pathways:

• Cytoskeletal organization pathway: Core component of neuronal cytoskeleton

• Synaptic plasticity pathway: Postsynaptic scaffolding

• MAP kinase signaling: Regulated by phosphorylation

• Axonal transport pathway: Facilitates intracellular transport

Animal Models

Knockout Models

Map2 knockout mice exhibit:

• Motor deficits: Coordination and balance problems

• Learning impairments: Reduced spatial learning

• Dendritic abnormalities: Altered dendritic tree morphology

• Synaptic defects: Impaired synaptic plasticity

Transgenic Models

• MAP2 overexpression: Enhanced neuronal survival

• Mutant MAP2: Disease-like phenotypes

• Rescue experiments: Functional restoration

Expression Patterns

Brain Region Distribution

Cellular Localization

• Soma: Perikaryal cytoplasm

• Dendrites: High concentration in shafts and spines

• Synapses: Postsynaptic density

• Axons: Very low (distinguishes from tau)

Phosphorylation Regulation

Kinases Regulating MAP2

Phosphorylation States

• Highly phosphorylated: Reduced microtubule binding

• Hypophosphorylated: Tight microtubule association

• Dynamic regulation: Activity-dependent changes

See Also

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• PubMed

• KEGG Pathways